Pharmaceutical composition comprising a 5HT1 receptor agonist

Details for Australian Patent Application No. 2002358602 (hide)

Owner Glaxo Group Limited

Inventors Baker, Robert William; Dow, Alan David; Summers, Simon John; Westrup, Julian

Agent Davies Collison Cave

Pub. Number AU-B-2002358602

PCT Number PCT/EP02/13715

PCT Pub. Number WO2003/047552

Priority 0129117.8 05.12.01 GB

Filing date 4 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 26 May 2005

International Classifications

A61K 009/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 009/46 Medicinal preparations characterised by special physical form - effervescent

A61K 031/00

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 0129117.8 05.12.01 GB

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002358602

26 May 2005 Application Accepted

  Published as AU-B-2002358602

22 September 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358603-PYRIMIDIN4-HYDROXYLAMINETHER-DERIVATE , DEREN HERSTELLUNG UND VERWENDUNG

2002358601-METAL CORD FOR USE IN A TYRE CARCASS REINFORCEMENT